A Study of PR2527 in Participants With Relapsed/Refractory Hematologic Malignancies

Conditions:   Aggressive B-Cell Non-Hodgkin's Lymphoma;   Aggressive B-Cell NHL;   Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma;   Mantle Cell Lymphoma (MCL);   Richter's Syndrome Intervention:   Drug: PRT2527 Sponsor:   Prelude Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials